Junshi Biosciences Aims to Raise $4.77 Million From International Share Sale

What’s new: Shanghai Junshi Biosciences Co. Ltd. plans to raise 3.4 billion yuan ($4.77 million) by selling global depositary receipts (GDRs) to be listed on the SIX Swiss Exchange, the Chinese cancer drug maker said Monday.

The Shanghai-based company said it will offer as many as 68.3 million shares represented by the GDRs and accounting for up to of 8.91% of the company’s total of A-shares before the offering.